Unitedhealth Expected to Post Higher Profit Amid Rate Hikes

Dow Jones
Jul 16
 

UnitedHealth is scheduled to report its second-quarter financial results before the market opens on Thursday. Here is what to know.

REVENUE: The country's biggest health insurance company is expected to report $110.79 billion in sales, compared with $111.62 billion in the previous second quarter, according to FactSet.

NET PROFIT: The Eden Prairie, Minn.-based company is expected to post a profit of $4.17 billion, compared with a profit of $3.41 billion the year before, according to FactSet.

ADJUSTED EARNINGS PER SHARE: Adjusted earnings are expected to come in at $4.88 a share, compared with $4.08 a share the prior year.

The stock has gained 26% this year, and recently traded at $424.

WHAT TO WATCH

- UnitedHealth is undergoing several strategic initiatives that position it well for growth ahead, Truist analysts. The analysts see the company's $1.5 billion investment in artificial intelligence this year as a way to drive operational efficiency, reduced friction, interoperability and better consumer experience.

- Elevance Health, another major health insurer, reported on Wednesday that membership fell, particularly in its Affordable Care Act and Medicaid plans. The company is exiting several Medicaid markets as government health insurance costs rise. Elevance, UnitedHealth and other insurers have also been raising ACA rates and plan to continue to do so next year, The Wall Street Journal reported.

- UnitedHealth's rate hikes have also improved its positioning with ACA plans, while membership is expected to shrink by a third, the Truist analysts say. Medicaid margins are expected to stay negative this fiscal year, but the analysts think they will improve in 2027 and beyond. They also see Medicare expanding margins in 2026, and think UnitedHealth's margins will recover overall across government-sponsored programs.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

July 15, 2026 12:18 ET (16:18 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10